Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Dec. 6, 2023
Abstract
Background:
In
recent
years,
human
microbiome
studies
have
receivedincreasing
attention
as
this
field
is
considered
a
potential
source
for
clinicalapplications.
With
the
advancements
in
omics
technologies
and
AI,
researchfocused
on
discovery
biomarkers
microbime
usingmachine
learning
tools
has
produced
positive
outcomes.
Despite
promisingresults,
several
issues
can
still
be
found
these
such
datasets
withsmall
number
of
samples,
inconsistent
results,
lack
uniform
processing
andmethodologies,
other
additional
factors
lead
to
reproducibility
inbiomedical
research.
work,
we
propose
methodology
that
combines
theDADA2
pipeline
16s
rRNA
sequences
Recursive
EnsembleFeature
Selection
(REFS)
multiple
increase
andobtain
robust
reliable
results
biomedical
Results:
Three
experiments
were
performed
analysing
data
frompatients/cases
Inflammatory
Bowel
Disease
(IBD),
Autism
Spectrum
Disorder(ASD),
Type
2
Diabetes
(T2D).
each
experiment,
biomarkersignature
one
dataset
applied
further
validation.
Theeffectiveness
proposed
was
compared
with
featureselection
methods
K-Best
F-score
random
selection
baseline.
The
Area
Under
Curve
(AUC)
employed
measure
diagnosticaccuracy
used
metric
comparing
proposedmethodology
feature
methods.
Conclusions:
We
developed
reproducible
biomarker
discoveryfor
sequence
analysis,
addressing
related
withdata
dimensionality,
validation
across
independentdatasets.
findings
from
three
experiments,
9
different
datasets,show
achieved
higher
accuracy
toother
This
first
approach
increasereproducibility,
provide
results.
eLife,
Journal Year:
2024,
Volume and Issue:
unknown
Published: March 26, 2024
Coronavirus
disease
2019
(COVID-19)
is
a
respiratory
illness
caused
by
severe
acute
syndrome
coronavirus
2
(SARS-CoV-2)
that
displays
great
variability
in
clinical
phenotype.
Many
factors
have
been
described
to
be
correlated
with
its
severity,
and
microbiota
could
play
key
role
the
infection,
progression,
outcome
of
disease.
SARS-CoV-2
infection
has
associated
nasopharyngeal
gut
dysbiosis
higher
abundance
opportunistic
pathogens.
To
identify
new
prognostic
markers
for
disease,
multicentre
prospective
observational
cohort
study
was
carried
out
COVID-19
patients
divided
into
three
cohorts
based
on
symptomatology:
mild
(n
=
24),
moderate
51),
severe/critical
31).
Faecal
samples
were
taken,
analysed.
Linear
discriminant
analysis
identified
Mycoplasma
salivarium,
Prevotella
dentalis,
Haemophilus
parainfluenzae
as
biomarkers
microbiota,
while
bivia
timonensis
defined
faecal
microbiota.
Additionally,
connection
between
identified,
significant
ratio
P.
(faeces)
dentalis
M.
salivarium
(nasopharyngeal)
abundances
found
critically
ill
patients.
This
serve
novel
tool
identifying
cases.
Coronavirus
disease
2019
(COVID-19)
is
a
respiratory
illness
caused
by
severe
acute
syndrome
coronavirus
2
(SARS-CoV-2)
that
displays
great
variability
in
clinical
phenotype.
Many
factors
have
been
described
to
be
correlated
with
its
severity,
and
microbiota
could
play
key
role
the
infection,
progression,
outcome
of
disease.
SARS-CoV-2
infection
has
associated
nasopharyngeal
gut
dysbiosis
higher
abundance
opportunistic
pathogens.
To
identify
new
prognostic
markers
for
disease,
multicenter
prospective
observational
cohort
study
was
carried
out
COVID-19
patients
divided
into
three
cohorts
based
on
symptomatology:
mild
(n=24),
moderate
(n=51),
severe/critical
(n=31).
Faecal
samples
were
taken,
analyzed.
Linear
discriminant
analysis
identified
M.
salivarium
,
P.
dentalis
H.
parainfluenzae
as
biomarkers
microbiota,
while
bivia
timonensis
defined
faecal
microbiota.
Additionally,
connection
between
identified,
significant
ratio
(faeces)
(nasopharyngeal)
abundances
found
critically
ill
patients.
This
serve
novel
tool
identifying
cases.
Frontiers in Microbiology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 17, 2024
Allergic
rhinitis
(AR)
and
asthma
(AS)
are
two
of
the
most
common
chronic
respiratory
diseases
a
major
public
health
concern.
Multiple
studies
have
demonstrated
role
nasal
bacteriome
in
AR
AS,
but
little
is
known
about
airway
mycobiome
its
potential
association
to
inflammatory
diseases.
Here
we
used
internal
transcriber
spacers
(ITS)
1
2
high-throughput
sequencing
characterize
339
individuals
with
AR,
(ARAS),
AS
healthy
controls
(CT).
Seven
ten
14
abundant
fungal
genera
(
Malassezia,
Alternaria,
Cladosporium,
Penicillium,
Wallemia,
Rhodotorula,
Sporobolomyces,
Naganishia,
Vishniacozyma
,
nd
Filobasidium
)
cavity
differed
significantly
p
≤
0.049)
between
or
ARAS,
CT.
However,
none
same
varied
three
disease
groups.
The
mycobiomes
ARAS
patients
showed
highest
intra-group
diversity,
while
CT
lowest.
Alpha-diversity
indices
microbial
richness
evenness
only
0.024)
CT,
all
groups
significant
differences
0.0004)
structure
(i.e.,
beta-diversity
indices)
when
compared
samples.
Thirty
metabolic
pathways
(PICRUSt2)
were
differentially
(Wald’s
test)
patients,
them
associated
5-aminoimidazole
ribonucleotide
(AIR)
biosynthesis
over
(log2
Fold
Change
>0.75)
group.
AIR
has
been
pathogenesis
plants.
Spiec-Easi
networks
among
groups,
more
similar
interactions
their
members
than
those
mycobiome;
this
suggests
allergic
may
disrupt
connectivity
cavity.
This
study
contributes
valuable
data
results
understand
relationships
allergy-related
conditions.
It
demonstrates
for
first
time
that
mycobiota
varies
during
(with
without
comorbid
asthma)
reveals
specific
taxa,
relate
disease.
Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Dec. 6, 2023
Abstract
Background:
In
recent
years,
human
microbiome
studies
have
receivedincreasing
attention
as
this
field
is
considered
a
potential
source
for
clinicalapplications.
With
the
advancements
in
omics
technologies
and
AI,
researchfocused
on
discovery
biomarkers
microbime
usingmachine
learning
tools
has
produced
positive
outcomes.
Despite
promisingresults,
several
issues
can
still
be
found
these
such
datasets
withsmall
number
of
samples,
inconsistent
results,
lack
uniform
processing
andmethodologies,
other
additional
factors
lead
to
reproducibility
inbiomedical
research.
work,
we
propose
methodology
that
combines
theDADA2
pipeline
16s
rRNA
sequences
Recursive
EnsembleFeature
Selection
(REFS)
multiple
increase
andobtain
robust
reliable
results
biomedical
Results:
Three
experiments
were
performed
analysing
data
frompatients/cases
Inflammatory
Bowel
Disease
(IBD),
Autism
Spectrum
Disorder(ASD),
Type
2
Diabetes
(T2D).
each
experiment,
biomarkersignature
one
dataset
applied
further
validation.
Theeffectiveness
proposed
was
compared
with
featureselection
methods
K-Best
F-score
random
selection
baseline.
The
Area
Under
Curve
(AUC)
employed
measure
diagnosticaccuracy
used
metric
comparing
proposedmethodology
feature
methods.
Conclusions:
We
developed
reproducible
biomarker
discoveryfor
sequence
analysis,
addressing
related
withdata
dimensionality,
validation
across
independentdatasets.
findings
from
three
experiments,
9
different
datasets,show
achieved
higher
accuracy
toother
This
first
approach
increasereproducibility,
provide
results.